Opening book details…
About this Medicine article
138PD_PR Patient-reported outcomes (PROs) in ALEX: A phase III study of alectinib (ALEC) vs crizotinib (CRIZ) in non-small-cell lung cancer (NSCLC) by Perol, M.; Peters, S.; Pavlakis, N.; Levchenko, E.; Platania, M.; Oliveira, J.; Novello, S.; Karagiannis, T.; Zeaiter, A.; Dziadziuszko, R. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Perol, M.; Peters, S.; Pavlakis, N.; Levchenko, E.; Platania, M.; Oliveira, J.; Novello, S.; Karagiannis, T.; Zeaiter, A.; Dziadziuszko, R.
- Publisher
- Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 1556-1380)
- Published
- 2018
- Language
- EN
- Field
- Medicine (Health Sciences)